NEW YORK STATE COMMON RETIREMENT FUND – Vertex Pharmaceuticals Incorporated Transaction History
NEW YORK STATE COMMON RETIREMENT FUND portfolio value:
$136.22M
portfolio value
NEW YORK STATE COMMON RETIREMENT FUND quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -4.12% | -20.24K shares | -2.05M | $289.54 | 470.49K |
| Q2 2022 | share | Increase | +0.89% | 4.32K shares | 11.34M | $281.79 | 490.73K |
| Q1 2022 | share | Decrease | -0.70% | -3.43K shares | 19.36M | $260.97 | 486.41K |
| Q4 2021 | share | Decrease | -2.69% | -13.53K shares | 16.26M | $222.45 | 489.84K |
| Q3 2021 | share | Increase | +1.26% | 6.24K shares | -8.92M | $181.39 | 503.38K |
| Q2 2021 | share | Increase | +1.14% | 5.58K shares | -5.39M | $201.63 | 497.13K |
| Q1 2021 | share | Decrease | -3.92% | -20.05K shares | -15.28M | $214.89 | 491.54K |
| Q4 2020 | share | Decrease | -5.15% | -27.8K shares | -25.87M | $236.34 | 511.6K |
| Q3 2020 | share | Decrease | -4.62% | -26.13K shares | -17.39M | $272.12 | 539.4K |
| Q2 2020 | share | Decrease | -0.65% | -3.72K shares | 28.72M | $290.31 | 565.53K |
| Q1 2020 | share | Decrease | -0.20% | -1.12K shares | 10.57M | $237.95 | 569.25K |
| Q4 2019 | share | Decrease | -1.93% | -11.2K shares | 26.35M | $218.95 | 570.37K |
| Q3 2019 | share | Increase | +0.87% | 5K shares | -7.20M | $169.42 | 581.57K |
| Q2 2019 | share | Decrease | -12.58% | -83.00K shares | -15.59M | $183.38 | 576.57K |
| Q1 2019 | share | Decrease | -7.42% | -52.9K shares | 3.26M | $183.95 | 659.58K |
| Q4 2018 | share | Decrease | -5.93% | -44.9K shares | -27.91M | $165.71 | 712.48K |
| Q3 2018 | share | Decrease | -2.54% | -19.7K shares | 13.90M | $192.74 | 757.38K |
| Q2 2018 | share | Decrease | -2.62% | -20.9K shares | 2.01M | $169.96 | 777.08K |
| Q1 2018 | share | Decrease | -5.04% | -42.35K shares | 4.12M | $162.98 | 797.98K |
| Q4 2017 | share | Increase | +2.16% | 17.8K shares | 874K | $149.86 | 840.33K |
| Q3 2017 | share | Increase | +3.46% | 27.48K shares | 22.6M | $152.04 | 822.53K |
| Q2 2017 | share | Increase | +5.84% | 43.84K shares | 20.31M | $128.87 | 795.04K |
| Q1 2017 | share | Decrease | -1.59% | -12.09K shares | 25.91M | $109.35 | 751.20K |
| Q4 2016 | share | Increase | +0.47% | 3.6K shares | -10.02M | $73.67 | 763.3K |
| Q3 2016 | share | Increase | +0.30% | 2.3K shares | 1.10M | $87.21 | 759.7K |
| Q2 2016 | share | Increase | +8.56% | 59.7K shares | 9.69M | $86.02 | 757.4K |
| Q1 2016 | share | Increase | +10.78% | 67.9K shares | -23.78M | $79.49 | 697.7K |